Nicotine is proving to be a formidable carcinogen, say researchers who warn that nicotine-infused smoking cessation products may not be the safest way to help smokers quit.
Nicotine is one of 4,000 chemicals found in cigarette smoke. While many of these chemicals are recognised as carcinogens, nicotine has up until now only been considered addictive rather than carcinogenic.
It is heavily used in smoking cessation products in patches, gum, and now in the increasingly popular electronic cigarette, or e-cigarette.
Geneticist Jasmin Bavarva and Harold Garner, a professor of biological science, computer science, and basic science affiliated with the College of Science, the College of Engineering, and the Virginia Tech Carilion School of Medicine, found that nicotine causes thousands of mutations called single nucleotide polymorphisms (SNPs) in exposed cells, compared with control cells that were not exposed.
These patterns are similar to those identified in cells experiencing oxidative stress, which is a known precursor to cancer, according to the study published in the journal Oncotarget.
A previous study in journal PLOS One by the researchers looked at gene expression patterns caused by nicotine.
"These results are important because for the first time they directly measure large numbers of genetic variations caused only by nicotine, showing that nicotine alone can mutate the genome and initiate a cancer state," said Garner, director of the institute's Medical Informatics and Systems Division.
"This is particularly timely since nicotine is used as a smoking cessation therapeutic," Garner added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
